SCHEMBL29627775

SCHEMBL29627775

O=Cc1cccc(/C=C/c2ccccc2)c1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 5/20 0.47
TRPA1 O75762 3/20 0.47
LMNA P02545 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP2A6 P11509 1/20 0.43
ALOX5 P09917 1/20 0.42
MAPK1 P28482 1/20 0.42
GAA P10253 1/20 0.40
CHAT P28329 2/20 0.39
HDAC1 Q13547 1/20 0.39
DPYD Q12882 1/20 0.39
MAOB P27338 2/20 0.38
CYP19A1 P11511 1/20 0.38
MAOA P21397 1/20 0.38
DHFR P00374 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29627779 1.00 NFE2L2 (0.47) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL30958792 0.81 LMNA (0.62) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL192400 0.81 LMNA (0.62) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL24385991 0.81 LMNA (0.62) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL192399 0.81 LMNA (0.62) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL1232196 0.81 LMNA (0.58) LMNAKMT2AMEN1THRBBLM
SCHEMBL4951414 0.80 NFE2L2 (0.50) NFE2L2TRPA1KMT2AMEN1MAOB
SCHEMBL297693 0.80 NFE2L2 (0.50) NFE2L2TRPA1KMT2AMEN1MAOB
SCHEMBL897653 0.78 NFE2L2 (0.48) NFE2L2TRPA1LMNAKMT2AMEN1
SCHEMBL28051597 0.78 NFE2L2 (0.48) NFE2L2TRPA1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3994137-A1 HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-05-11 EP claimed
EP-3994137-A1 HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-05-11 EP disclosed